Akoustis Technologies Ord Shs
AKTS
View Detailed Chart
18.980USD
-0.590-3.01%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
2.93BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-3.01%
5 Days
-6.27%
1 Month
0.00%
6 Months
0.00%
Year to Date
0.00%
1 Year
0.00%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Akoustis Technologies Ord Shs News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Akoustis Technologies Ord Shs Info
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.
Ticker SymbolAKTS
CompanyAkoustis Technologies Ord Shs
CEORoden (Matthew)
Websitehttps://www.aktisoncology.com/
Related Instruments
0.00%
+0.42%
+0.45%
0.00%
+0.50%
+8.57%
+0.48%
0.00%
0.00%
+0.97%
+0.68%
0.00%
+9.08%
+0.44%
-1.39%
-0.09%
+0.86%
-0.29%
0.00%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
67826.760
-2143.370 (-3.06%)
282.580
+22.390 (+8.61%)
2001.040
-50.690 (-2.47%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
